NEW YORKMay 13, 2026 /PRNewswire/ — Univest Securities, LLC, a member of FINRA and SIPC and a full-service investment bank and securities broker-dealer, today announced that it has completed a $6.5 million registered direct offering (the “Offering”) for its client, Haoxi Health Technology Limited (the “Company” or “Haoxi Health Technology”) (NASDAQ: HAO). Haoxi Health Technology is a Beijing-based technology company primarily engaged in providing online marketing solutions to clients in the healthcare industry, with a focus on short video and news feed advertising on major digital platforms in China.
Pursuant to the terms of the securities purchase agreement, the Company agreed to sell to certain investors in the Offering 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”), and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per Share. The purchase price for each pre-funded warrant equals the purchase price for the Shares, less an exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 ordinary shares.
The gross proceeds to the Company from the Offering were approximately $6.5 million, before deducting placement agent fees and other offering expenses payable by the Company.
Univest Securities, LLC acted as the sole placement agent for the Offering.
The registered direct offering was conducted pursuant to the Company’s effective shelf registration statement on Form F-3 (File No. 333-287686), previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective on June 13, 2025. A final prospectus supplement and accompanying base prospectus describing the terms of the Offering have been filed with the SEC and are available on the SEC’s website at http://www.sec.gov. Electronic copies may be obtained by contacting Univest Securities, LLC via email at info@univest.us, or by mail to: Univest Securities, LLC, 75 Rockefeller Plaza, Suite 25A, New York, NY 10019, or by calling +1 (212) 343-8888. Additionally, electronic copies of the offering documents are available on the SEC’s website at www.sec.gov.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Univest Securities, LLC
Univest Securities, LLC has been registered with FINRA since 1994, providing a wide range of financial services to its global institutional and retail clients, including brokerage and execution services, sales and trading, market making, investment banking and advisory, and wealth management. It is committed to delivering value-added services to its clients and focuses on building long-term relationships. As a well-known institution on Wall Street, Univest Securities has successfully raised over $1.8 billion in capital for global issuers and completed approximately 100 transactions covering a variety of investment banking services since 2019, spanning industries such as technology, life sciences, industrials, and consumer goods. For more information, please visit: www.univest.us.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a China-based online marketing solutions provider headquartered in Beijing, focusing on serving advertisers in the healthcare industry. The Company’s growth benefits from the rise of news feed advertising and the rapid development of the healthcare industry. It offers one-stop online marketing solutions, with a particular focus on online short video marketing, helping advertisers acquire and retain customers on major Chinese platforms such as Jinri Toutiao, Douyin, WeChat, and Sina Weibo. The Company is dedicated to helping advertisers reduce costs, improve efficiency, and provide convenient online marketing solutions.
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding plans, objectives, strategies, future events or performance, and underlying assumptions and other statements that are not historical facts. When the Company uses words such as “may,” “will,” “intends,” “should,” “believes,” “expects,” “anticipates,” “projects,” “estimates,” or similar expressions (which are not solely related to historical matters), it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including but not limited to uncertainties related to market conditions and whether the initial public offering will be completed on the anticipated terms or at all, as well as other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, investors should not place undue reliance on any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available at www.sec.gov. Univest Securities, LLC and the Company undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances occurring after the date of this press release.
For more information, please contact: